News

MedPage Today26d
Registry Data Reassure on JAK Inhibitors' Heart Risks
TNF inhibitors used in JAK-pot registries included adalimumab, etanercept, infliximab (Remicade), certolizumab pegol (Cimzia), and golimumab (Simponi ... biologic disease-modifying antirheumatic ...
Nasdaq6d
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara ... a proposed biosimilar for Simponi® (golimumab) and Simponi Aria® (golimumab ...
The Manila Times6d
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) ...